Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory disease

被引：30
|
作者：
Al-Janabi, A. [1 ]
Littlewood, Z. [1 ]
Griffiths, C. E. M. [1 ]
Hunter, H. J. A. [1 ]
Chinoy, H. [2 ,3 ,4 ]
Moriarty, C. [5 ]
Yiu, Z. Z. N. [1 ]
Warren, R. B. [1 ]
机构：
[1] Univ Manchester, Salford Royal NHS Fdn Trust, Dermatol Ctr, Manchester NIHR Biomed Res Ctr, Manchester M6 8HD, Lancs, England
[2] Univ Manchester, Manchester Univ NHS Fdn Trust, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England
[3] Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Dept Rheumatol, Salford, Lancs, England
[4] Univ Manchester, Ctr Musculoskeletal Res, Fac Biol Med & Hlth, Manchester, Lancs, England
[5] Imperial Coll London White City Campus, Affin Biomarker Labs, Translat & Innovat Hub Bldg, London W12 0BZ, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
10.1111/bjd.20479
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：646 / 648
页数：3
相关论文
共 50 条
  • [21] Immunogenicity and safety of standard and third dose SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases; a prospective cohort study
    Jorgensen, K. K.
    Syversen, S. W.
    Jyssum, I.
    Tveter, A. T.
    Tran, T. T.
    Sexton, J.
    Provan, S. A.
    Mjaaland, S.
    Warren, D. J.
    Kvien, T. K.
    Grodeland, G.
    Nissen-Meyer, L. S.
    Ricanek, P.
    Chopra, A.
    Andersson, A. M.
    Kro, G. B.
    Jahnsen, J.
    Munthe, L. A.
    Haavardsholm, E. A.
    Vaage, J. T.
    Lund-Johansen, F.
    Goll, G. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I537 - I538
  • [22] Immunogenicity and safety of standard and third dose SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases; a prospective cohort study
    Jorgensen, K. K.
    Syversen, S. W.
    Jyssum, I.
    Tveter, A. T.
    Tran, T. T.
    Sexton, J.
    Provan, S. A.
    Mjaaland, S.
    Warren, D. J.
    Kvien, T. K.
    Grodeland, G.
    Nissen-Meyer, L. S.
    Ricanek, P.
    Chopra, A.
    Andersson, A. M.
    Kro, G. B.
    Jahnsen, J.
    Munthe, L. A.
    Haavardsholm, E. A.
    Vaage, J. T.
    Lund-Johansen, F.
    Goll, G. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I537 - I538
  • [23] Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
    Syversen, Silje Watterdal
    Jyssum, Ingrid
    Tveter, Anne Therese
    Sexton, Joe
    Christensen, Ingrid Egeland
    Tran, Trung T.
    Bjorlykke, Kristin Hammersboen
    Mjaaland, Siri
    Warren, David J.
    Kvien, Tore K.
    Chopra, Adity
    Kro, Grete Birkeland
    Jahnsen, Jorgen
    Munthe, Ludvig A.
    Haavardsholm, Espen A.
    Grodeland, Gunnveig
    Vaage, John Torgils
    Provan, Sella Aarrestad
    Jorgensen, Kristin Kaasen
    Goll, Guro Lovik
    RMD OPEN, 2022, 8 (02):
  • [24] IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY
    Reddy, Kavya
    Grody, Wayne W.
    Sarkissian, Ariella
    Getzug, Terri
    GASTROENTEROLOGY, 2022, 162 (07) : S287 - S287
  • [25] Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
    Wieske, Luuk
    van Dam, Koos P. J.
    Steenhuis, Maurice
    Stalman, Eileen W.
    Kummer, Laura Y. L.
    van Kempen, Zoe L. E.
    Killestein, Joep
    Volkers, Adriaan G.
    Tas, Sander W.
    Boekel, Laura
    Wolbink, Gerrit J.
    van der Kooi, Anneke J.
    Raaphorst, Joost
    Lowenberg, Mark
    Takkenberg, R. Bart
    D'Haens, Geert R. A. M.
    Spuls, Phyllis, I
    Bekkenk, Marcel W.
    Musters, Annelie H.
    Post, Nicoline F.
    Bosma, Angela L.
    Hilhorst, Marc L.
    Vegting, Yosta
    Bemelman, Frederike J.
    Voskuyl, Alexandre E.
    Broens, Bo
    Sanchez, Agner Parra
    van Els, Cecile A. C. M.
    de Wit, Jelle
    Rutgers, Abraham
    de Leeuw, Karina
    Horvath, Barbara
    Verschuuren, Jan J. G. M.
    Ruiter, Annabel M.
    van Ouwerkerk, Lotte
    van der Woude, Diane
    Allaart, Renee C. F.
    Teng, Y. K. Onno
    van Paassen, Pieter
    Busch, Matthias H.
    Jallah, Papay B. P.
    Brusse, Esther
    van Doorn, Pieter A.
    Baars, Adaja E.
    Hijnen, Dirk Jan
    Schreurs, Corine R. G.
    van der Pol, W. Ludo
    Goedee, H. Stephan
    Keijzer, Sofie
    Keijser, Jim B. D.
    LANCET RHEUMATOLOGY, 2022, 4 (05): : E338 - E350
  • [26] SEROLOGICAL RESPONSE AND SAFETY OF A THREE-DOSE SARS-COV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY
    Jyssum, I.
    Tveter, A. T.
    Sexton, J.
    Christensen, I. E.
    Tran, T. T.
    Mjaaland, S.
    Warren, D. J.
    Kvien, T. K.
    Bjorlykke, K. H.
    Kro, G. B.
    Jahnsen, J.
    Munthe, L. A.
    Haavardsholm, E. A.
    Vaage, J. T.
    Grodeland, G.
    Lund-Johansen, F.
    Provan, S. Aarrestad
    Jorgensen, K. K.
    Goll, G. L.
    Syversen, S. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 127 - 128
  • [27] Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
    Simon, David
    Tascilar, Koray
    Kroenke, Gerhard
    Kleyer, Arnd
    Zaiss, Mario M.
    Heppt, Franz
    Meder, Christine
    Atreya, Raja
    Klenske, Entcho
    Dietrich, Peter
    Abdullah, Abdullah
    Kliem, Thorsten
    Corte, Giulia
    Morf, Harriet
    Leppkes, Moritz
    Kremer, Andreas E.
    Ramming, Andreas
    Pachowsky, Milena
    Schuch, Florian
    Ronneberger, Monika
    Kleinert, Stefan
    Maier, Clara
    Hueber, Axel J.
    Manger, Karin
    Manger, Bernhard
    Berking, Carola
    Tenbusch, Matthias
    Ueberla, Klaus
    Sticherling, Michael
    Neurath, Markus F.
    Schett, Georg
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [28] Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
    David Simon
    Koray Tascilar
    Gerhard Krönke
    Arnd Kleyer
    Mario M. Zaiss
    Franz Heppt
    Christine Meder
    Raja Atreya
    Entcho Klenske
    Peter Dietrich
    Abdullah Abdullah
    Thorsten Kliem
    Giulia Corte
    Harriet Morf
    Moritz Leppkes
    Andreas E. Kremer
    Andreas Ramming
    Milena Pachowsky
    Florian Schuch
    Monika Ronneberger
    Stefan Kleinert
    Clara Maier
    Axel J. Hueber
    Karin Manger
    Bernhard Manger
    Carola Berking
    Matthias Tenbusch
    Klaus Überla
    Michael Sticherling
    Markus F. Neurath
    Georg Schett
    Nature Communications, 11
  • [29] Longitudinal antibody response to SARS-CoV-2 infection and antibody responses to COVID-19 vaccination in Inflammatory Bowel Disease patients receiving biologics
    Wong, S. Y.
    Dixon, R.
    Gold, S.
    Vicky, M.
    Helmus, D.
    Cadwell, K.
    Colombel, J. F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S380 - S381
  • [30] Immune Response to Single-Dose Moderna Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2
    Moreira-Pinto, Joao
    Gregorio, Susana
    Camarinha, Joao
    Soares, Bruno
    Cunha Ramos, Joao
    ACTA MEDICA PORTUGUESA, 2021, 34 (09): : 630 - 631
12345